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Abstract: The clinical and haematological findings in dairy cattle with naturally infected bovine immunodeficiency virus (BIV)
infection were evaluated. Thirty-seven (12.3%) out of 300 cattle that had previously been found positive for BIV infection were
monitored. Thirty-seven BIV-free cattle selected from BIV-positive herds were used as a control group. Routine clinical and
haematological parameters were recorded 6 times, at 1-month intervals.
Mastitis (n = 18), metritis (n = 9), respiratory system diseases (n = 8), retained placenta (n = 7), and regional lymphadenopathy
(n = 7) were predominantly diagnosed during the monitoring period in BIV-infected cattle, and mastitis (n = 1) and metabolic
disturbance (n = 1) in the control animals. Heart and respiratory rates were significantly higher (P < 0.01) in BIV-infected cattle
than in the control group. White blood cell (WBC) count and lymphocyte rate were lower (P < 0.01) in BIV-infected cattle, but the
neutrophil rate was higher (P < 0.05) than those of the control group. There were no significant differences in erythrocyte or
platelet indices within or between the groups during the study.
These findings suggest that the presence of BIV infection should be considered a health risk to cattle populations, and may have a
role in changing WBC and differential cell counts in the host.
Key Words: Bovine immunodeficiency virus, BIV, clinical disorders, blood parameters, cattle

S›¤›r ‹mmun Yetmezlik Virusu (BIV) ile
Enfekte S›¤›rlarda Klinik ve Hematolojik Bulgular
Özet: Sunulan bu çal›ﬂmada s›¤›r immun yetmezlik virusu (BIV) ile dogal enfekte süt s›¤›rlar›n›n klinik ve hematolojik bulgular›
de¤erlendirildi. Üç yüz s›¤›r aras›ndan BIV enfeksiyonu yönünden pozitif bulunan 37 s›¤›r (% 12,3) de¤erlendirmeye al›nd›. BIV
pozitif sürülerden seçilen BIV negatif 37 s›¤›r kontrol grubu olarak kullan›ld›. Rutin klinik ve hematolojik parametreler bir ay arayla
alt› kez kaydedildi.
Gözlem sürecinde, BIV ile enfekte s›¤›rlarda öncelikli olarak mastitis (n = 18), metritis (n = 9), solunum sistemi hastal›klar› (n = 8),
retentio secundinarum (n = 7), ve bölgesel lenfadenopati (n = 7), kontrol grubunda ise mastitis (n = 1) ve metabolik hastal›klar (n
= 1) tan›mland›. BIV ile enfekte s›¤›rlar›n kalp ve solunum say›lar› kontrol grubuna göre anlaml› düzeyde (P < 0,01) yüksek bulundu.
Kontrol grubu ile karﬂ›laﬂt›r›ld›¤›nda, BIV ile enfekte s›¤›rlarda total lökosit ve lenfosit say›s› daha düﬂük (P < 0,01), buna ra¤men
nötrofil oranlar› daha yüksek (P < 0,05) belirlendi. Çal›ﬂma sürecinde grup içi ve gruplar aras›nda eritrosit ve trombosit indekslerinde
istatiksel farkl›l›k belirlenemedi.
Bu bulgular BIV enfeksiyonunun s›¤›r populasyonu için bir sa¤l›k riski oluﬂturabilece¤ini ve konakç›da total lökosit ve formül lökosit
say›lar›n›n de¤iﬂiminde rol oynayabilece¤ini göstermektedir.
Anahtar Sözcükler: S›¤›r immun yetmezlik virusu, BIV, klinik bozukluklar, kan parametreleri, s›¤›r

* E-mail: zyilmaz@uludag.edu.tr
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Introduction
Bovine immunodeficiency virus (BIV) is classified in
the genus lentivirus, of the family Retroviridae (1-6).
However, lentiviruses in general are transmitted both
horizontally and vertically and the route and mechanism
of natural transmission in cattle are largely unknown
(5,7,8). Serological investigations have shown wide
distribution with differing prevalence (1.4% to 80%) of
BIV infections around the world (1-7).
Although several pathological changes have been
reported in BIV-infected cattle, including monocyte
dysfunction, encephalopathy, lymphadenopathy, and
immunodeficiency, the detailed pathogenesis of BIVinfected cattle remains unclear (1-7,9). Given the
similarity of this virus to human immunodeficiency virus
(HIV) and the pathogenic activity of most lentiviruses in
the infected host, it is reasonable to assume that BIV
should cause disease in cattle (10). BIV seropositivity has
been associated with decreased milk production in dairy
cattle, but has not been directly linked to clinical disease
in naturally infected cattle (4-7,10,11). However, Walder
et al. (12) reported evidence for a possible association
between bovine paraplegic syndrome and a viral agent
related to BIV. Snider et al. (13) determined that a herd
with high seroprevalence of BIV had a high percentage of
cows with encephalitis associated with depression and
stupor, alteration of the immune system associated with
secondary bacterial infections, and chronic inflammation
of the feet and legs. In some cases, BIV-infected animals
could be co-infected with bovine leukaemia virus (BLV),
which can cause lymphoid tumours in the host, which
commonly remains clinically and haematologically normal
(7,14-18).
Experimental (19-22) and clinical evidence (10,18)
showed that immune suppressive effects of BIV might be
related to functional impairment of lymphocytes. Some
authors (10,18) reported that no significant differences
were found in total leukocyte populations or leukocyte
subpopulations between BIV seropositive or seronegative
animals; however, others (7,14,15,18) reported that BIV
per se and a dual infection with BLV caused persistent
lymphocytosis in cows. Circulating neutrophils and
eosinophils were also reported to increase in BIVinoculated sheep (23). Based on the accumulated
evidence, it is difficult to decide whether BIV induces
specific clinical and/or haematological syndromes in the
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host. Thus, this study was performed to evaluate whether
routine clinical and haematological findings vary in BIVinfected dairy cattle in comparison to those in healthy
controls. Clinical manifestations shown in cows in
examined herds were recorded over 6 months in order to
start a discussion on the incidence of clinical problems
between BIV infected and non-infected cows. Recent
advances in automated blood cell analysers have made it
possible to give further information about complete blood
cell count. Unfortunately, limited research has been
reported on erythrocyte and platelet indices in cattle
practice (24), and it is unknown yet whether these indices
change in response to BIV infection. However, anaemia
and thrombocytopaenia are often reported in patients
with HIV (25,26). Therefore, erythrocyte and platelet
indices were examined at the same time intervals in this
study as well.

Materials and Methods
Animals
A total of 300 blood samples from cattle of Holstein
(n = 294) and Simmental breeds (n = 6), in 4 different
cities: Balıkesir, Bursa, Çanakkale, and Tekirda¤ (Table
1), in the Marmara region (Turkey), were screened for
anti-BIV antibodies (16). For this purpose, serum was
separated by centrifugation at 3000 rpm for 10 min,
heat inactivated and stored at -20 °C until sent to the
Laboratory of Infectious Diseases, Hokkaido Univ., Japan
by absorption on filter paper. BIV infection status of the
cattle had been determined by Western blotting. Selected
seropositive animals (n = 37; 12.3%) were further

Table 1. Detection of anti-BIV antibodies in cattle in Turkey.*
City

Number of
cattle tested**

Number of cattle
seropositive for BIV (%)

Bal›kesir

50

6 (12.0)

Tekirda¤

41

4 (9.7)

Bursa

151

20 (13.2)

Çanakkale

58

7 (12.0)

Total

300

37 (12.3)

* Data summarised from Ref. 16
** The tested cattle were older than 1 year, and all were Holstein
breed, except 6 of Simmental breed in Çanakkale.
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sampled for confirmation of BIV infection by proviral DNA
detection in buffy coat samples using nested polymerase
chain reaction (PCR). BIV infected animals were
monitored in the farm environment for the following 6
months for clinical and laboratory assessments. In this
study, age matched BIV seropositive (test group, n = 37)
and seronegative animals (control group, n = 37), of the
same breed and lactation period, were used to assess any
effect of BIV infection on clinical and haematological
parameters. Control animals were selected from among
BIV-seronegative cattle from the same herds including
BIV-positive animals in 4 different cities. These cases
were not further analysed for other infectious agents like
viruses and bacteria that may play a role in that kind of
clinical disorder. All the animals studied here were
clinically normal at the first sampling time. Average age
was 5.5 years in the test group and 4.6 years in the
control group.
Measurements
Routine clinical and haematological parameters were
obtained from test and control animals. Records were
collected 6 times during visits once a month. Body
temperature and heart and respiratory rates were
recorded and external lymph nodes were examined by
palpation. Peripheral (jugular) blood samples were
collected from both groups and used to establish
leukogram [total white blood cells (WBCs) and
differential leukocyte counts], erythrogram [red blood
cells (RBCs), haemoglobin (Hgb), haematocrit (Hct), and
RBC indices: mean corpuscular volume (MCV), mean
corpuscular haemoglobin concentration (MCHC), mean
corpuscular haemoglobin (MCH), and RBC distribution
width (RDW)], and thrombogram [platelet count and
platelet indices: mean platelet volume (MPV), plateletcrit
(PCT), and platelet distribution width (PDW)], by use of
an automatic haematology analyser (Cell Dyne 3500,
Abbott, Wiesbaden, Germany).
Statistical analysis
All data were evaluated by one way analysis of
variance (ANOVA) followed by Tukey test for pairwise
comparisons (SigmaStat 2.0, GmbH, Germany). Clinical
and haematological data in BIV-seropositive and BIVseronegative groups were also compared using Student's
t-test. P values less than 0.05 were considered
significant. Results were expressed as mean ± SEM.

Results
Historical information from BIV-infected cattle
revealed that the predominant diseases diagnosed during
the observation period were mastitis (n = 18), metritis
(n = 9), and respiratory system diseases (n = 8) (Table
2). At the same time, in the control group, mastitis (n =
1) and metabolic disturbance (n = 1) were diagnosed.
During the monitoring period, there were no significant
differences in temperatures between BIV-infected and
control animals (Table 3). Heart and respiratory rates
observed at 2-6 months were significantly higher (P <
0.01) in BIV-infected cattle than in control animals.
Of the haematological parameters, total WBC counts
3
3
between 4.2 ± 0.7 × 10 /µl and 5.8 ± 1.1 × 10 /µl at 24 months were significantly lower (P < 0.01) in BIVinfected cattle, compared to those (6.4 ± 1.0 × 103/µl to
9.1 ± 2.2 × 103/µl) in the controls. Neutrophil leukocytes
ranging from 63 ± 10% to 88 ± 11% in BIV-infected
animals were significantly higher (P < 0.05) than those
(35 ± 9%-41 ± 5%) of control animals during the
observation period. Lymphocyte rates were lower
between 1 and 6 months in BIV-infected animals than in
the controls (Table 4). Eosinophils, monocytes, and
basophils rates did not vary within or between the groups
(Table 4). RBC count ranged from 5.4 × 106/µl to 5.8 ×
106/µl and 5.5 × 106/µl to 6.3 × 106/µl in test and control
animals, throughout the study, respectively (Table 5).
Haematocrit, haemoglobin, and RBC indices (MCV, MCH,
MCHC, and RDW) varied insignificantly during the study
in both groups. As shown in Table 6, variations in platelet
count and platelet indices (MPV, PCT, and PDW) were not
statistically significant between or within groups from the
first sampling time to the end of the monitoring period.

Table 2. Clinical problems observed in 37 BIV-infected cattle.
Clinical problems

n (%)

Mastitis

18 (48.6)

Metritis

9 (24.3)

Respiratory system diseases

8 (21.6)

Retained placenta

7 (18.9)

Regional lymphadenopathy

7 (18.9)

Metabolic disturbance

6 (16.2)

Abomasal ulcer

2 (5.4)

Abomasal depletion

1 (2.7)
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Table 3. Selected clinical parameters in healthy controls (n = 37) and BIV infected cattle (n = 37).
Months (Mean ± SEM)
Parameters

Groups

Temperature °C

Heart rate/min

Respiration/min

P
1

2

3

4

5

6

Control

38.4 ± 0.5

38.3 ± 0.3

38.1 ± 0.8

38.6 ± 0.6

38.4 ± 0.4

38.3 ± 0.8

NS

Infected

38.7 ± 1.2

38.2 ± 0.8

38.1 ± 0.9

38.8 ± 0.8

38.3 ± 0.9

38.0 ± 0.7

NS

Control

72.3 ± 7.6

68.7 ± 5.4

78.4 ± 3.2

82.3 ± 4.0

66.7 ± 4.4

76.4 ± 3.1

NS

Infected

84.2 ± 2.8

†

94.3 ± 2.2

68.4 ± 3.6

84.1 ± 6.8

†

78.3 ± 4.2

†

88.4 ± 4.9

NS

Control

12.1 ± 4.2

14.2 ± 3.1

16.1 ± 3.0

13.0 ± 3.2

15.3 ± 4.3

16.2 ± 3.0

NS

Infected

16.1 ± 6.4

20.2 ± 5.3†

14.4 ± 4.1

†

26.6 ± 5.2*

†

24.2 ± 4.1

†

27.5 ± 5.4*

NS

NS: not significant
†

Significant differences (P < 0.01) between control and BIV-infected groups.
* P < 0.05 versus value observed at 1st month

Table 4. White blood cell (WBC) and differential count in healthy controls (n = 37) and BIV-infected cattle (n = 37).
Months (Mean ± SEM)
Parameters

Groups

P
1

2

3

4

5

6

WBC count × 103/µL Control

8.4 ± 1.5

6.4 ± 1.0

8.9 ± 2.6

9.1 ± 2.2

8.4 ± 1.3

7.5 ± 1.9

NS

Infected

4.4 ± 0.8†

4.2 ± 0.7†

4.6 ± 1.2†

4.3 ± 2.4†

5.5 ± 3.4

5.8 ± 1.1

<0.05

Segment

Control

35.2 ± 9.4

38.3 ± 8.4

38.1 ± 6.3

41.2 ± 5.3

34.5 ± 6.7

36.3 ± 7.4

NS

Neutrophil %

Infected

68.4 ± 6.8†

63.1 ± 10.3†

78.7 ± 6.7†

69.5 ± 12.4†

88.2 ± 11.3*†

65.4 ± 9.3†

<0.05

Lymphocyte %

Control

55 ± 10

54 ± 9

52 ± 7

56 ± 9

61 ± 6

59 ± 7

NS

Infected

27 ± 6†

34 ± 7†

29 ± 6†

27 ± 5†

10 ± 4**†

30 ± 5†

<0.01

Control

4±2

4±1

6±2

2±2

3±2

2±0

NS

Infected

1±1

2±0

1±1

1±0

1±1

3±2

NS

Control

5±2

3±2

3±2

1±0

2±1

2±1

NS

Infected

3±1

1 ± 1†

2±1

2±0

1±1

2±1

NS

Control

1±0

1±0

0±0

0±0

0±0

0±0

NS

Infected

1±0

0±0

0±0

0±0

0±0

0±0

NS

Eosinophils %

Monocytes %

Basophils %

NS: Not significant
†

P < 0.01; significant differences between control and BIV-infected groups

* P < 0.05 and ** P < 0.01; versus values observed at 1st visit
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Table 5. Red blood cell (RBC) count and RBC indices in healthy controls (n = 37) and BIV-infected cattle (n = 37).
Months (Mean ± SEM)
Parameters

1

2

3

4

5

6

P
value

RBC count × 103/µL Control

6.1 ± 1.6

6.3 ± 1.3

5.5 ± 1.2

5.8 ± 1.1

6.0 ± 1.2

5.9 ± 1.4

NS

Infected

5.6 ± 0.9

5.7 ±1.4

5.8 ± 1.0

5.6 ± 1.4

5.4 ± 1.1

5.5 ± 1.0

NS

Control

34 ± 3

36 ± 4

32 ± 2

29 ± 3

33 ± 4

32 ± 3

NS

Infected

31 ± 4

34 ± 2

33 ± 3

32 ± 3

33 ± 2

33 ± 2

NS

Control

11 ± 2

12 ± 3

9±2

9±3

10 ± 2

9±3

NS

Infected

10 ± 3

11 ± 2

10 ± 3

9±3

10 ± 4

11 ± 2

NS

Control

56 ± 5

57 ± 3

58 ± 4

50 ± 5

55 ± 3

59 ± 7

NS

Infected

55 ± 4

59 ± 3

56 ± 2

57 ± 4

60 ± 4

60 ± 5

NS

Control

18 ± 3

19 ± 2

16 ± 4

16 ± 3

16 ± 4

16 ± 3

NS

Infected

17 ± 4

19 ± 3

17 ± 5

17 ± 5

18 ± 5

19 ± 4

NS

Control

32 ± 4

33 ± 4

29 ± 3

31 ± 4

30 ± 3

29 ± 4

NS

Infected

32 ± 5

32 ± 5

30 ± 4

29 ± 3

31 ± 4

32 ± 3

NS

Control

18 ± 3

16 ± 4

20 ± 3

19 ± 3

18 ± 4

17 ± 4

NS

Infected

16 ± 4

17 ± 3

18 ± 4

17 ± 5

18 ± 3

18 ± 5

NS

Haematocrit %

Haemoglobin g/dl

MCV fl

MCH g/dl

MCHC pg

RDW %

Groups

MCV: Mean corpuscular volume; MCH: Mean corpuscular haemoglobin;
MCHC: Mean corpuscular haemoglobin concentration; RDW: RBC distribution width
NS: Not significant

Table 6. Platelet count and indices in healthy controls (n = 37) and BIV-infected cattle (n = 37).
Months (Mean ± SEM)
Parameters

Groups
1

2

3

4

5

6

P
value

Platelet count

Control

320 ± 30

360 ± 80

340 ± 70

310 ± 90

330 ± 60

350 ± 70

NS

× 10 /µL

Infected

360 ± 40

300 ± 60

290 ± 50

270 ± 40

320 ± 70

300 ± 80

NS

MPV fl

Control

15 ± 3

12 ± 4

15 ± 3

16 ± 2

17 ± 3

16 ± 3

NS

Infected

18 ± 4

16 ± 3

17 ± 4

17 ± 3

15 ± 2

17 ± 3

NS

Control

0.5 ± 0.1

0.4 ± 0.1

0.5 ± 0.1

0.5 ± 0.0

0.5 ± 0.0

0.6 ± 0.1

NS

Infected

0.6 ± 0.1

0.5 ± 0.0

0.5 ± 0.0

0.4 ± 0.1

0.5 ± 0.1

0.5 ± 0.1

NS

Control

17 ± 2

18 ± 3

19 ± 3

18 ± 4

17 ± 3

19 ± 2

NS

Infected

14 ± 3

15 ± 4

16 ± 3

17 ± 4

15 ± 2

16 ± 4

NS

3

PCT %

PDW %

MPV: Mean platelet volume; PCT: Plateletcrit; PDW: Platelet volume distribution width
NS: Not significant
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Discussion
Seroepidemiological studies of BIV infections in cattle
have been reported in many countries (1-7,9,13),
including Turkey (16). Despite the worldwide distribution
of BIV infection, whether the presence of BIV in a host
leads to primarily pathologic changes or can cause
secondary bacterial and/or viral infections as a
predisposition factor has not been fully elucidated. Under
practical conditions, infection with BIV has a different
effect on the host than has been observed under
experimental conditions (17). The presence of BIV
combined with the stresses associated with parturition
and a modern dairy production system was considered
causal for the development of secondary diseases in
immunocompromised cattle (8,17). In this study, during
a 6-month observation period, the frequent development
of concurrent infections in BIV-infected animals (Table 2)
suggested that persistent BIV infection had a role in
reducing functional immune competence, in accordance
with other studies (17-19). In a previous study (17), the
secondary disease processes and their incidence, including
metritis (12%), subcutaneous abscesses (18%), purulent
arthritis (18%), infectious pododermatitis and laminitis
(37%), and mastitis (56%), were reported. It is
interesting to note, like previously reported (17), that in
the present study mastitis was the most common
problem during BIV infection, most probably due to BIV
induced immune dysfunction with a decreased CD4/CD8
ratio (17-19) and its transmission by milk (6,8). In the
same study (17), clinical signs such as weight loss,
reduced vitality, torpidity, dullness, and stupor in
response to BIV were also reported. Metabolic
disturbances (16%) observed in the study may be related
to the clinical neurogenic anorexia observed in BIVinfected calves (17).
Regional lymphadenopathy in response to BIV has
been reported in natural and experimental conditions
(17). In the present study, the lymphadenopathy
observed, probably due to an increased lymphocyte
proliferation to BIV gag protein (19), may be interpreted
as a useful diagnostic finding indicating the presence of
BIV infection. Increased lymphocytic blastogenic activity
in response to BIV (27) may also be a possible reason for
the lymphadenopathy observed in this study. However,
Snider et al. (17) reported that the enlarged lymph nodes
in response to BIV did not represent the presence of
lymphosarcoma. Hidalgo and Bonilla (20) reported that,

212

due to the high rate of dual infections observed in Costa
Rica, leukocytosis and lymphocytosis were not sufficient
to clarify which virus is responsible for the suppressive
activity, if one or both viruses are necessary, or if they act
synergistically. During the monitoring period, there were
no significant differences in body temperatures between
BIV-infected and control animals (Table 3). Heart and
respiratory rates observed at 2-6 months were
significantly higher (P < 0.01) in BIV-infected cattle than
in control animals, suggesting that these differences are
most probably due to the clinical problems observed.
Studies showed that the BIV infection delayed
antibody responses and decreased antibody titres to
bovine herpesvirus type 1 (19) and bovine respiratory
syncytial virus infection in cattle (27). Some studies
(19,28) suggested that BIV may have a role as a
predisposing factor for other viral diseases. Based on the
our study design, it is difficult to decide whether the
changes in circulating WBC counts and neutrophils rates
were due to primarily BIV infection or secondary
bacterial/other viral diseases. In contrast, some authors
(10,17,18) reported that no significant differences were
found in WBC populations and subpopulations between
BIV seropositive or seronegative animals. Our observation
that circulating lymphocytes were lower in BIV-infected
cattle than in control animals was in contrast to a
previous report (17) including lymphocytosis in 6 of 15
cows with BIV. In addition, Jacobs et al. (23) reported
that neutrophil and eosinophil rates increased 3 months
after BIV inoculation in sheep. Taken together, these
conflicting data indicate that the role of BIV in the
pathophysiological mechanism of bovine clinical diseases
remains unclear.
It is well known that immunodeficiency viruses can
cause bone marrow suppression, resulting in
thrombocytopaenia and anaemia (25,26). Erythrocyte
and platelet indices provide clinical information on the
underlying conditions of anaemia and thrombocytopaenia
(29). In particular, erythrocyte mean corpuscular volume
(MCV) and mean platelet volume (MPV) have been
reported to be indirect signs of disturbance of
erythrocyte and platelet production and bone marrow
response to infections (29). In the present study,
erythrocyte and platelet indices did not differ within or
between the groups, suggesting that BIV has no influence
on the number, volume (MCV and MPV), or distribution
width (RBC and PDW) in erythrocyte or platelets. This
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observation may be related to the lower pathogenicity of
BIV and duration of disease and infection, as reported
earlier (1-7,9).
This study has some limitations. First, it is difficult to
know whether the clinical and haematological disorders
observed were due to BIV infection alone, because of the
fact that BIV-positive cattle were not further analysed for
other infectious agents like viruses or bacteria that may
play a role in that kind of clinical disorder. Second, it is
difficult to select uniform patient and control populations
in animal studies. Therefore, control animals were
selected from among BIV-seronegative cattle from the
same herds including BIV-positive animals, because of the
fact that some factors, i.e. climate, magnitude of farm,
and management, are well known to affect the health
status of dairy cattle. Thirdly, the number of lactations
could have been recorded in the present study. The fact
that there was no significant difference in age between
the groups (5.5 years vs. 4.6 years) may have minimised

the effects of lactation on clinical and haematological
differences between them. Cavirani et al. (10) reported
that clinical consequences of BIV infection might best be
detected in older animals as well.
These findings suggest that the presence of BIV
infections should be considered a health risk for cattle
populations, and may have a role in the changes in WBC
and differential cell counts in the host. Erythrocyte and
platelet indices might be unchanged for 6 months in BIVinfected cattle. Further studies in a larger patient
population are required to verify these observations.
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